LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, and Zesty Paws®, the #1 Selling Pet Supplement Brand in the USA*, are entering the longevity category, a highly desirable consumer segment, with the debut of Healthy Aging NAD+ Precursor, featuring ChromaDex’s industry leading cellular health ingredient, Niagen (patented nicotinamide riboside or NR).

洛杉矶-（商业线）-全球烟酰胺腺嘌呤二核苷酸（NAD+）和健康老龄化研究权威机构ChromaDex Corp.（纳斯达克股票代码：CDXC），以及美国＃1销售宠物补充品牌Zesty Paws®*，正在进入长寿类别，一个非常受欢迎的消费细分市场，健康老龄化NAD+前体的首次亮相，以ChromaDex行业领先的细胞健康成分Niagen（专利烟酰胺核糖苷或NR）为特色。

This supplement can help promote metabolic health and cellular energy and repair for dogs..

这种补充剂可以帮助促进狗的代谢健康和细胞能量以及修复。。

NAD+ is an essential coenzyme that plays a vital role in cellular processes including mitochondrial function, cellular energy production, and DNA repair. Backed by the highest scientific rigor and quality standards, the key ingredient in this supplement is Niagen, which is formulated to help support the regeneration of NAD+ levels in dogs..

NAD+是一种必需的辅酶，在细胞过程中起着至关重要的作用，包括线粒体功能，细胞能量产生和DNA修复。在最高的科学严谨性和质量标准的支持下，本补充剂的关键成分是Niagen，其配方有助于支持狗的NAD+水平的再生。。

“We remain steadfast in our mission to provide the transformative power of our precious Niagen (NR) ingredient to every animal cell on this planet, including to our beloved canine companions,” said ChromaDex CEO, Rob Fried. “As the global authority on NAD+ and healthy aging research, and the creators of the most superior and efficient NAD+ booster, we are proud to partner with Zesty Paws to enhance the healthy aging journey for our pooches.”.

Rob Fried首席执行官ChromaDex说：“我们坚定地致力于为这个星球上的每个动物细胞，包括我们亲爱的犬伴，提供我们珍贵的烟碱（NR）成分的变革力量。“作为NAD+和健康老龄化研究的全球权威机构，以及最优越和最有效的NAD+助推器的创始者，我们很自豪地与Zesty Paws合作，为我们的贵宾犬提供健康的老龄化旅程。”。

Bob Kalil, vice president of product development for Zesty Paws (part of H&H Group), said, “By combining the ideals of science and nature and upholding the brand’s commitment of quality and trusted ingredients included in every formula, we were able to create a groundbreaking product that benefits the healthy aging of dogs inside and out.

Zesty Paws（H＆H Group的一部分）产品开发副总裁Bob Kalil说：“通过结合科学和自然的理想，坚持品牌对每种配方中包含的质量和可信成分的承诺，我们能够创造一种有利于狗内外健康老化的开创性产品。

While this category is in its early stages, our product innovation is a very exciting example of what’s to come for supporting longevity for pets.”.

虽然这个类别还处于早期阶段，但我们的产品创新是支持宠物长寿的一个非常令人兴奋的例子。

The Healthy Aging NAD+ Precursor pack from Zesty Paws, that launched exclusively with Chewy this month, includes one bottle of 60 capsules of Niagen (NR) and one jar of the brand’s bacon-flavored Pill Wrap Probiotic Paste.

来自Zesty Paws的健康老化NAD+前体包装本月仅推出Chewy，包括一瓶60粒Niagen胶囊（NR）和一罐该品牌的培根味药丸包裹益生菌糊。

“Our Healthy Aging line was designed to bring a bit of your dog’s puppyhood back. By replenishing their NAD+ levels, this breakthrough innovation can help promote cell regeneration and support healthy aging, allowing our beloved pets to maintain their vitality and zest for life,” said Yvethe Tyszka, vice president of marketing for Zesty Paws (part of H&H Group)..

“我们的健康老龄化生产线旨在为您的狗带来一点点幼犬。通过补充NAD+水平，这一突破性创新可以帮助促进细胞再生并支持健康老龄化，使我们亲爱的宠物能够保持其活力和对生活的热情，”Zesty Paws营销副总裁Yvethe Tyszka说（H＆H集团的一部分）。。

The Healthy Aging line will expand in early 2024 with additional distribution and the launch of a powdered format.

健康老龄化生产线将于2024年初扩大，并进一步分销并推出粉末形式。

For additional information on Niagen, visit Chromadex.com and for more information about Zesty Paws, please visit ZestyPaws.com.

有关Niagen的更多信息，请访问Chromadex.com，有关Zesty Paws的更多信息，请访问ZestyPaws.com。

About ChromaDex

关于ChromaDex

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®.

ChromaDex Corp.是一家致力于健康老龄化的全球生物科学公司。包括世界知名科学家在内的ChromaDex团队正在对烟酰胺腺嘌呤二核苷酸（NAD+）进行开创性研究，其水平随着年龄的增长而下降。ChromaDex是NAD+前体烟酰胺核苷（NR）的创新者，作为旗舰成分Niagen®商业化。

Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company..

烟酰胺核苷和其他NAD+前体受ChromaDex专利组合的保护。ChromaDex在www.ChromaDex.com维护一个网站，ChromaDex定期向该网站发布其新闻稿的副本以及有关该公司的其他财务信息。。

About H&H Group, North America

关于H＆H集团，北美

H&H Group is a global health and nutrition company with three growing business segments in North America – Baby, Adult and Pet Nutrition and Care – supporting whole-family health and happiness through premium brands providing nutrition and wellness solutions backed by science to pets and people. The consumer brands include Zesty Paws, the #1 Selling Pet Supplement Brand in the USA*, Solid Gold Pet, America’s first holistic pet nutrition company, as well as children’s nutrition brand, Biostime, and vitamin, supplement, and skincare brand, Swisse..

H＆H集团是一家全球健康和营养公司，在北美拥有三大业务领域-婴儿，成人和宠物营养和护理-通过优质品牌为宠物和人们提供科学支持的营养和保健解决方案，支持全家庭健康和幸福。消费品牌包括Zesty Paws，＃1美国销售宠物补充剂品牌*，固体金宠物，美国第一家整体宠物营养公司，以及儿童营养品牌，Biostime，维生素，补充剂和护肤品牌Swisse。。

*Source Euromonitor International Limited; Pet Supplements category as per Passport Ecommerce. All channels included, excluding vets, volume sales in units, more info at https://zestypaws.com/pages/claim.

*来源Euromonitor International Limited；宠物补充剂类别根据护照电子商务处。包括所有渠道，不包括兽医，单位销售量，更多信息https://zestypaws.com/pages/claim.

Forward-Looking Statements:

前瞻性声明：

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, including statements related to the launch of Niagen in the pet segment. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as 'expects,' 'anticipates,' 'intends,' 'estimates,' 'plans,' 'potential,' 'possible,' 'probable,' 'believes,' 'seeks,' 'may,' 'will,' 'should,' 'could' or the negative of such terms or other similar expressions.

本版本包含1933年“证券法”（修订版）第27A条和1934年“证券交易法”（修订版）第21E条含义内的前瞻性声明，包括与Niagen在宠物细分市场。不是对历史事实的描述的陈述构成前瞻性陈述，并且通常（但不总是）可以通过使用诸如“期望”，“预期”，“意图”，“估计”，“计划，“潜力”，“可能”，“可能”，“相信”，“寻求”，“可能”，“将会”，“应该”或这些术语或其他类似表达的否定。

Risks that contribute to the uncertain nature of these forward-looking statements include the impact of the COVID-19 pandemic on our business and the global economy; our history of operating losses and need to obtain additional financing; the growth and profitability of our product sales; our ability to maintain sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; and the risks and uncertainties associated with our business and financial condition.

导致这些前瞻性声明性质不确定的风险包括COVID-19大流行对我们业务和全球经济的影响；我们的经营损失历史和需要获得额外融资；我们产品销售的增长和盈利能力；我们保持销售，营销和分销能力的能力；改变消费者对我们产品的看法；我们依赖单一或有限数量的第三方供应商；以及与我们的业务和财务状况相关的风险和不确定性。

More detailed information about ChromaDex and the risk factors that may affect the realization of forward-looking statements is set forth in ChromaDex's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, ChromaDex's Quarterly Reports on Form 10-Q and other filings submitted by ChromaDex to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov.

有关ChromaDex的更详细信息以及可能影响实现前瞻性报表的风险因素，请参阅ChromaDex在截至2022年12月31日的财政年度10-K表格年度报告，ChromaDex关于表格10-Q的季度报告和ChromaDex向SEC提交的其他文件，其副本可从SEC网站www.SEC.gov获取。

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by th.

提醒读者不要过分依赖这些前瞻性陈述，这些前瞻性陈述仅在其签署之日起发言，实际结果可能与th所建议的实质性结果大不相同。